A recent study indicates that BRAF mutant tumors, which are enriched in our Wnt‐low tumor group, elicit lower levels of mitochondrial respiration than KRAS mutant or wild‐type tumors (Rebane‐Klemm et al, 2020). The gene discussed is KRAS; the disease is neoplasm.